Al Hammadi Holding Announces the Results of the Extraordinary General Assembly Meeting, ( First Meeting )

Element ListExplanation
IntroductionThe Board of Directors of Al Hammadi holding is pleased to announce the results of the Extraordinary General Assembly Meeting (First Meeting)
City and Location of the General Assembly’s MeetingRiyadh City – using Tadawulaty system
Date of the General Assembly’s Meeting2024-06-30 Corresponding to 1445-12-24
Time of the General Assembly’s Meeting20:25
Percentage of Attending Shareholders58,8%
Names of the Board of Directors’ Members Present at the General Assembly’s Meeting and Names of the AbsenteesThe following Board Members attended the meeting:1. Dr. Abdulaziz Mohammed Alhammadi (Chairman)2. Mr. Mohammed Saleh Alhammadi (Deputy Chairman)3. Dr. Abdulaziz Saleh Alhammadi (Board Member)4. Mr. Aziz Mohammed Algahtani (Board Member)5. Mr. Fahad Suliman Alnuhait (Board Member)6. Mr. Saad Abdulmohsen Alhamidi (Board Member)7. Dr. Nasser Hamd Binsaif (Board Member)Absence:Dr. Ahmed Ibraheem Alsagheir (Board Member)
Names of the Chairmen of the Committees Present at the General Assembly’s Meeting or Members of such Committees Attending on Their BehalfThe following Committees’ Chairmen attended the meeting:1. Mr. Aziz Mohammed Algahtani (Chairman of the Audit Committee)2. Mr. Saad Abdulmohsen Alhamidi (Chairman of the Nomination and Remuneration Committee)
Voting Results on the Items of the General Assembly’s Meeting Agenda’s1. Reviewed and discussed the report of the Board of Directors for the fiscal year ended December 31, 2023 AD.2. Reviewed and discussed the company’s financial statements for the fiscal year ended December 31, 2023 AD.3. Approved the independent auditor’s report for the fiscal year ended December 31, 2023 AD.4. Approved appointing BDO Dr.Muhammed Al-Amri & co. independent auditor from the candidates based on the recommendations of the Audit Committee for the audit and review of the financial statements for the second and third quarters and the annual statements for the year 2024 AD and the first quarter of the year 2025 AD with total fees of (1,051,100) SAR.5. Approved to release the members of the Board of Directors from liability for their management during the fiscal year ended December 31, 2023 AD.6. Approved the amendment of the company’s Articles of Association to conform to the new Companies Law, and rearranging and numbering the Articles of Association to conform to the proposed amendments.7. Approved the amendment of Article (6) of the company’s Articles of Association related to duration of the company.8. Approved the amendment of Article (21) of the company’s Articles of Association related to powers of the board.9. Approved the amendment of Article (23) of the company’s Articles of Association related to powers of the Chairman, Vice Chairman, Managing Director, and Secretary.10. Approved the payment of bonuses to the members of the Board of Directors for the fiscal year ended December 31, 2023 AD, with a total amount of (1,600,000) Riyals.11. Approved delegating the Board of Directors with the authority to distribute interim dividends on a semi-annual or quarterly basis for the fiscal year 2024 AD.12. Approved delegating the of Board of Directors with the authority of the Ordinary General Assembly with the authorization contained in Paragraph (1) of Article (27) of the Companies Law, for a period of one year from the date of approval of the General Assembly or until the end of the delegated Board of Directors session, whichever is earlier, in accordance with the conditions contained in the Implementing Regulations of the Companies Law for Listed Joint Stock Companies.13. Approved transferring the balance of the statutory reserve amounting to (67,355,941) riyals as in the financial statements for the year ended December 31, 2023 AD to a general reserve.14. Approved the transactions that will be carried out between the company and Aziz Company for Contracting and Industrial Investment, in which the Chairman of the Board of Directors, Dr. Abdulaziz Mohammad Al Hammadi, and the Vice Chairman of the Board, Mr. Mohammad Saleh Al Hammadi, and the board member Dr. Abdulaziz Saleh Al Hammadi have an indirect interest in them, noting that the nature of the transaction consists of purchase orders for support and supply services, and the value of the transaction during the previous year 2023 AD amounted to (531,163) Riyals, noting that there are no preferential terms.15. Approved the transactions that will be carried out between the company and Al Hammadi for Information Technology Establishment, in which the Vice Chairman of the Board, Mr. Mohammad Saleh Al Hammadi, has an indirect interest, the Chairman of the Board, Dr. Abdulaziz Mohammad Al Hammadi, and the members of the Board, Dr. Abdulaziz Saleh Al Hammadi have an indirect interest, noting that the nature of the transactions is purchase orders for technical services, and the value of the transactions during the previous year 2023 AD amounted to (956,189) Riyals, noting that there are no preferential terms.16. Approved the transactions that will be carried out between the company and Artal Food Trading Establishment, in which the Board member, Dr. Nasser Hamad Binsaif, has an indirect interest, noting that the nature of the transactions is purchase orders for support and supply services, and the value of the transactions during the previous year 2023 AD amounted to (5,732,306) Riyals, noting that there are no preferential terms.

Pharmaceutical Services

Pharmaceutical Services Company, a subsidiary of Al Hammadi Holding, is a leading provider of essential medications, vaccinations, and drug distribution services. As a key component of Al Hammadi’s comprehensive health care offering, the Pharmaceutical Services Company plays a vital role in ensuring that patients have access to the necessary treatments to support their health and well-being.

Continuing Medical Education (CME)

The Continuing Medical Education (CME) was established in 1985 to meet the education and training needs of all hospital staff, whether medical personnel, doctors or non-medical staff nurses, assistants or technicians.

Training Institutes Women

The Support Services Institutes for Training opened branches for (women) in Riyadh, Kingdom of Saudi Arabia in 2020, after the complete acquisition (100%) of Najd Training Institutes, which was established in 1986 AD. Thus, the Support Services Institutes have become one of the leading and specialized institutes in the field of training and education. and development.

Training Institutes Men

The Support Services Institutes for Training opened branches for(Men) in Riyadh, Kingdom of Saudi Arabia in 2020, after the complete acquisition (100%) of Najd Training Institutes, which was established in 1986 AD. Thus, the Support Services Institutes have become one of the leading and specialized institutes in the field of training and education. and development.

Sudair Pharmaceutical

Sudair Pharmaceutical Company (SPC) is a leading Saudi-based pharmaceutical firm specializing in specialty care medications. Established in 2014, SPC aims to address unmet medical needs in Saudi Arabia and the MENA region, with a focus on cancer-fighting medications and other high-tech treatments for chronic and life-threatening diseases. Al Hammadi Holding Company owns 35% of SPC’s shares, bolstering its commitment to improve healthcare provision and secure the supply of advanced pharmaceuticals. SPC’s innovative business model, international partnerships, and dedication to integrity, quality, innovation, and community service make it an integral player in achieving KSA’s 2030 vision for better health outcomes.

Biopharma Industrial Park

The Biopharma Industrial Park is a progressive subsidiary of Al Hammadi Holding, operating at the forefront of biotechnology and life sciences innovation. As a pivotal contributor to Al Hammadi’s comprehensive health care services, the Biopharma Industrial Park is committed to driving advancements in medical research, development, and production. Its focus on cutting-edge technologies and scientific expertise enables the organization to make significant strides in improving patient care, as well as advancing the medical sector within the Kingdom of Saudi Arabia and beyond.

Construction & Maintenance

The Construction and Maintenance Company is a subsidiary of Al Hammadi Holding, specializing in providing high-quality hospital maintenance, engineering works, and other related services. As an integral part of the Al Hammadi group, this company plays a crucial role in ensuring the smooth and efficient functioning of health care facilities while maintaining a safe and comfortable environment for patients and medical staff, the company recently obtained certificates in quality, safety and environmental management.

Home Medical Care

Home Medical Care, a subsidiary of Al Hammadi Holding, provides comprehensive and personalized healthcare services to patients in the comfort of their own homes. This innovative approach to healthcare delivery aims to enhance patient satisfaction, reduce hospital readmissions, and improve overall patient outcomes. By offering a wide range of medical services in a familiar and comfortable environment, Home Medical Care strives to promote patient well-being and independence.

Telemedicine

Telemedicine Company, a subsidiary of Al Hammadi Holding, is at the forefront of revolutionizing healthcare delivery by leveraging advanced technology to provide remote medical services. This innovative approach to healthcare enables patients to access quality medical care from the comfort of their homes or workplaces, eliminating geographical barriers and reducing the burden on traditional healthcare facilities.

Unified Procurement

Unified Procurement, a subsidiary of Al Hammadi Holding, is a specialized company responsible for managing all medical and non-medical hospital purchases and supplies. As an integral part of Al Hammadi’s comprehensive health care services, Unified Procurement plays a vital role in ensuring that hospitals and clinics have access to the necessary equipment, supplies, and consumables needed to provide high-quality care to their patients.

Arabian Hospitality

Arabian Hospitality, a subsidiary of Al Hammadi Holding, is a prominent player in the domain of hospital support services, dedicated to maintaining the highest standards of hygiene, laundry, medical staff attire, and food services for patients. As an integral part of the Al Hammadi Holding group, Arabian Hospitality ensures a seamless and comfortable experience for both patients and medical staff, contributing to the overall excellence of the group’s health care offerings, the company recently obtained the certificates of Quality Management, Food Safety, Hazard Analysis and Critical Control Points.

Al Hammadi Hospital Al Narjis

Al Narjis Hospital – Expected launch in 2028 .Building on this, Al Hammadi is expecting to launch its fourth hospital in 2028. The facility will have a capacity of 200 rooms and 120 clinics and will house two centers of excellence focused on rehabilitation and plastic surgery. The facility will be located in Al Narjis neighborhood in the north of the Kingdom’s capital.

Al Hammadi Hospital Al Olaya

Al Olaya Hospital – Expected Launch in 2026 .Al Olaya Hospital was Al Hammadi’s first facility, originally launched back in 1985. At its peak, the facility was home to 200 inpatient rooms and 74 outpatient clinics. The facility was temporarily shut down in the final months of 2021 as management kicked off an extensive renovation plan aimed at constructing a new facility with a new infrastructure and a broader service offering. The revamped facility, which is planned to reopen in 2026, will have a capacity of 200 rooms and 120 clinics and will operate two centers of excellence focused on sports medicine and oncology. The facility is located in the Al Olaya neighborhood of Riyadh, which has historically been a business, commerce, and leisure hub in the city, rendering it a natural residential destination for expats and a large number of Saudi citizens.

Al Hammadi Hospital Al Suwaidi

Launched in 2015, Al Suwaidi Hospital is located in a strategic southwest neighborhood of KSA’s capital. Today, the facility houses 300 inpatient rooms, 80 outpatient clinics, and 13 operating rooms. The facility also has a cardiac catheterization room, two upper and lower endoscopy rooms, a kidney stone treatment room, and a lithotripsy room. The facility is equipped with the highest quality machinery and medical technology in the market, and services are provided by highly trained and experienced medical professionals. As of year-end 2022, 160 rooms were operational at the facility, with the remaining unutilized rooms offering easy-to-ramp-up capacity to match growing demand. The facility caters to both a significant pool of patients associated with the MOH and private insurance patients primarily from the medium and medium-upper class segment.

Al Hammadi Hospital Al Nuzha

Located in a northeast neighborhood of Riyadh and officially inaugurated in 2018, Al Nuzha Hospital was originally launched to cater predominately to medium and upper-medium class patients, leveraging its 300-room capacity, 100 outpatient clinics, and 13 operating rooms. In 2022, the facility continued its premiumization, converting double rooms into single rooms to cater to increasing demand from higher-income class A/VIP patients and enabling the Group to capitalize on the important growth opportunities offered by this expanding segment. Today, Al Nuzha Hospital offers a comprehensive range of medical services, all provided by the facility’s highly experienced medical staff